Who owns the KANGIO (BIVALIRUDIN) INJECTION trademark?

The KANGIO (BIVALIRUDIN) INJECTION trademark is owned by Eagle Pharmaceuticals, Inc..

What class is the KANGIO (BIVALIRUDIN) INJECTION trademark registered in?

The KANGIO (BIVALIRUDIN) INJECTION trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for KANGIO (BIVALIRUDIN) INJECTION?

The USPTO serial number for KANGIO (BIVALIRUDIN) INJECTION is 86851093.

What is the registration number for KANGIO (BIVALIRUDIN) INJECTION?

KANGIO (BIVALIRUDIN) INJECTION is registered under USPTO registration number 0.

KAN

USPTO Trademark Record

ABANDONED

KANGIO (BIVALIRUDIN) INJECTION

SN 86851093·Reg 0·Filed Dec 16, 2015

Owner Eagle Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

KANGIO (BIVALIRUDIN) INJECTION (Serial No. 86851093), Registration No. 0, is a abandoned US trademark filed on Dec 16, 2015 by Eagle Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

KANGIO (BIVALIRUDIN) INJECTION (Reg. #0) is an abandoned US trademark that was filed in 2015 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 16, 2015

SERIAL

86851093

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Eagle Pharmaceuticals, Inc.

Entity

Corporation

State

Address

50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ, 07677

Country

Attorney

NameMICHELLE ELIZABETH LEGIEC

Address

24 SPRINGFIELD AVE, APT 20, 50 TICE BOULEVARD, SUITE 315, WOODCLIFF LAKE, NJ 07677, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateDec 16, 2015

Serial Number86851093

Registration No.0

Registration DateDec 31, 1969

Status DateAug 04, 2016

Published for OppositionMay 31, 2016

Mark TypeDesign with words

Status DescriptionDead and abandoned due to express abandonment after publication

Filing Signals

FILED

2015

YEARS AGO

11y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Apr 27, 2026

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

ABANDONMENT - AFTER PUBLICATION

Aug 04, 2016

ABANDONMENT - AFTER PUBLICATION

ABANDONMENT NOTICE MAILED - AFTER PUBLICATION

Aug 04, 2016

ABANDONMENT NOTICE MAILED - AFTER PUBLICATION

WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST

Jul 18, 2016

WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST

PUBLISHED FOR OPPOSITION

May 31, 2016

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 31, 2016

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

TEAS EXPRESS ABANDONMENT RECEIVED

May 23, 2016

TEAS EXPRESS ABANDONMENT RECEIVED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 11, 2016

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Apr 28, 2016

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Apr 21, 2016

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 09, 2016

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 08, 2016

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 08, 2016

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 08, 2016

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Apr 03, 2016

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 03, 2016

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 03, 2016

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 02, 2016

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Dec 22, 2015

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 21, 2015

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 19, 2015

NEW APPLICATION ENTERED

KANGIO (BIVALIRUDIN) INJECTION

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Eagle Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by MICHELLE ELIZABETH LEGIEC

Resources

Company